Clinical trial
Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
NCT00422084 · Medicines for Malaria Venture, Other · Completed
Key facts
| NCT number | NCT00422084 |
|---|---|
| Title | Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients |
| Official title | A Phase III Comparative (Double-blind, Double-dummy) Randomised, Multi-centre Study to Assess the Efficacy of Pyronaridine Artesunate (180:60mg) Versus Coartem® (Artemether Lumefantrine) in Children & Adult Patients With Falciparum Malaria |
| Lead sponsor | Medicines for Malaria Venture, Other |
| Collaborators | Shin Poong Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Pyronaridine artesunate, Coartem® (artemether lumefantrine) |
| Enrollment | 1,272 |
| Start date | Jan 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jan 15, 2007 |
| Last update posted | Nov 2, 2021 |
| Countries | Democratic Republic of the Congo, Ghana, Indonesia, Kenya, Mali, Mozambique, Philippines, Senegal, The Gambia |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: